Clinical Response to Traditional Chinese Herbs Containing Realgar (As₂S₂) is Related to DNA Methylation Patterns in Bone Marrow DNA from Patients with Myelodysplastic Syndrome with Multilineage Dysplasia

References

• Lwenberg B. Introduction to a review series on myelodysplastic syndromes. Blood. 2019;133(10):1001. doi:10.1182/blood-2018-12-88654930670447
   PubMed Web of Science ®Google Scholar
• Hosono N. Genetic abnormalities and pathophysiology of MDS. Int J Clin Oncol. 2019;24(8):885–892. doi:10.1007/s10147-019-01462-631093808
   PubMed Web of Science ®Google Scholar
• Bewersdorf JP, Zeidan AM. Evolving therapies for lower-risk myelodysplastic syndromes. Ann Hematol. 2020;99:677–692.32078008
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zhu Q, Wang H, et al. Traditional Chinese medicine containing arsenic treated MDS patients effectively through regulating aberrant hypomethylation. Evid Based Complement Alternat Med. 2020;7469809.32215045
   PubMed Web of Science ®Google Scholar
• Zhu Q, Deng Z, Zhu S, et al. Study on the clinical safe and effective methods of arsenic-containing compound-Qinghuang powder in the treatment of myelodysplastic syndrome. Evid Based Complement Alternat Med. 2017. doi:10.1155/2017/2095682
   Web of Science ®Google Scholar
• Zhang TD, Rong FX. Cancer 1 injection and differentiation in the treatment of acute myelocytic leukemia. Heilongjiang Medi J. 1979;(4):7–10.
   Google Scholar
• Chen SJ, Chen Z. Targeting agents alone to cure acute promyelocytic leukemia. N Engl J Med. 2013;369(2):186–187. doi:10.1056/NEJMe130476223841735
   PubMed Web of Science ®Google Scholar
• Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008;111(5):2505–2515. doi:10.1182/blood-2007-07-10279818299451
   PubMed Web of Science ®Google Scholar
• Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet. 2009;10(11):805–811. doi:10.1038/nrg265119789556
   PubMed Web of Science ®Google Scholar
• Van Tongelen A, Loriot A, De Smet C. Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Lett. 2017;396(28):130–137. doi:10.1016/j.canlet.2017.03.02928342986
   PubMed Web of Science ®Google Scholar
• Jaroslav J, Shoudan L, Frank N, et al. Cancer drivers affected by aberrant DNA methylation in MDS and AML. Blood. 2011;118(21):1716. doi:10.1182/blood.V118.21.1716.171621852444
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-64354427069254
   PubMed Web of Science ®Google Scholar
• Tefferi A, Barosi G, Mesa RA, et al. International working group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia: on behalf of the IWG for myelofibrosis research and treatment (IWGMRT). Blood. 2006;108(5):1497–1503. doi:10.1182/blood-2006-03-00974616675707
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079–2088. doi:10.1182/blood.V89.6.20799058730
   PubMed Web of Science ®Google Scholar
• Aoki-Kinoshita KF, Kanehisa M. Gene annotation and pathway mapping in KEGG. Methods Mol Biol. 2007;396:71–91.18025687
   PubMedGoogle Scholar
• Gonzalez-Fierro A, Dueñas-González A. Emerging DNA methylation inhibitors for cancer therapy: challenges and prospects. Expert Rev Precis Med Drug Dev. 2019;4(1):27–35. doi:10.1080/23808993.2019.1571906
   Web of Science ®Google Scholar
• Santini V. How I treat MDS after hypomethylating agent failure. Blood. 2019;133(1):521–529. doi:10.1182/blood-2018-03-78591530545832
   PubMed Web of Science ®Google Scholar
• Lin J, Qian J, Yao DM, et al. Aberrant hypomethylation of SALL4 gene in patients with myelodysplastic syndrome. Leuk Res. 2013;37(1):71–75. doi:10.1016/j.leukres.2012.10.01423122807
   PubMed Web of Science ®Google Scholar
• Wu DH, Yao DM, Yang L, et al. Hypomethylation of let-7a-3 is associated with poor prognosis in myelodysplastic syndrome. Leuk Lymphoma. 2017;58(1):96–103. doi:10.1080/10428194.2016.118727327244225
   PubMed Web of Science ®Google Scholar
• Eden A, Gaudet F, Waghmare A, et al. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 2003;300(5618):455. doi:10.1126/science.108355712702868
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci. 2009;66(14):2249–2261. doi:10.1007/s00018-009-0015-519326048
   PubMed Web of Science ®Google Scholar
• Wu H, Chen Y, Liang J, et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature. 2005;438(7070):981–987. doi:10.1038/nature0422516355216
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang C, Li Y, Li P, Zhang D, Li C. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo. Cancer Chemother Pharmacol. 2019;83(3):519–530. doi:10.1007/s00280-018-3755-930542770
   PubMed Web of Science ®Google Scholar
• Hu XM, Yuan B, Tanaka S, et al. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines. Hematology. 2014;19(6):352–360. doi:10.1179/1607845413Y.000000013824192507
   PubMed Web of Science ®Google Scholar
• Xu M, Ren JY, Guo YC, et al. Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro. Leuk Res. 2017;62:4–11. doi:10.1016/j.leukres.2017.09.01028963909
   PubMed Web of Science ®Google Scholar
• Zhou QB, Liu ZT, Wang HZ, Guo XQ, Xu YG, Hu XM. Arsenic disulfide promoted hypomethylation by increasing DNA methyltransferases expression in myelodysplastic syndrome. Drug Des Devel Ther. 2020;14:1641–1650. doi:10.2147/DDDT.S239158
   PubMed Web of Science ®Google Scholar